Study tests combination immunotherapy in advanced bile duct cancer
Cholangiocarcinoma, also known as bile duct cancer, is steadily rising in incidence worldwide. Symptoms often go undetected until the disease is far advanced. Surgical resection […]
Cholangiocarcinoma, also known as bile duct cancer, is steadily rising in incidence worldwide. Symptoms often go undetected until the disease is far advanced. Surgical resection […]
Hoosier Cancer Research Network, formerly known as Hoosier Oncology Group, recently honored Olumide Gbolahan, MD, as the 2016 recipient of the George and Sarah Jane Fisher […]
Indiana University cancer researchers are testing whether therapy incorporating advanced genomic technology will provide better outcomes than current treatments for those with an aggressive form […]
Indiana University School of Medicine researchers have discovered how to predict whether triple negative breast cancer will recur, and which women are likely to remain […]
Memorial Sloan Kettering Cancer Center (MSK) is the world’s oldest and largest private cancer center, home to more than 20,000 physicians, scientists, nurses, and staff […]
The Bladder Cancer Genomics Consortium (BCGC) and Hoosier Cancer Research Network today announced the selection of Caris Life Sciences® to perform genomic profiling for UC-GENOME, […]
Noah Hahn, MD, recently concluded his tenure as chief scientific officer of the Hoosier Oncology Group and associate professor of medicine at the Indiana University […]
The Pancreatic Cancer Action Network (PanCAN) is dedicated to fighting the world’s toughest cancer. In our urgent mission to save lives, we attack pancreatic cancer […]
The Prostate Cancer Foundation (PCF) is the world’s leading philanthropic organization funding and accelerating prostate cancer research. Founded in 1993, PCF has raised more than […]
The Cholangiocarcinoma Foundation (CCF)’s mission is to find a cure and improve the quality of life for those affected by cholangiocarcinoma (bile duct cancer). Founded […]
Rutgers Cancer Institute of New Jersey is offering a Hoosier Cancer Research Network clinical trial (HCRN GI16-288) targeting an advanced form of colorectal cancer with […]
The Sandra Turner Excellence in Clinical Research Award was established in 2002 by Dr. William B. Fisher through the George and Sarah Jane Fisher Fund […]
A single arm phase II study, LUN15-299, for patients who have been previously treated for mesothelioma is being conducted by the Hoosier Cancer Research Network […]
The Breast Cancer Research Foundation is a nonprofit organization committed to achieving prevention and a cure for breast cancer. We provide critical funding for cancer […]
Richard Kim, MD, service chief of Medical Gastrointestinal Oncology and senior member in the Gastrointestinal Oncology Department at Moffitt Cancer Center, has been appointed as […]
Hoosier Cancer Research Network investigators presented the ongoing study LUN18-335, RAMOSE: An open-label randomized Phase II study of osimertinib with or without ramucirumab in TKI-naïve […]
A Phase II Trial of VP-16, Ifosfamide and Cisplatin (VIP) Combination Chemotherapy for Previously Untreated Extensive Small Cell Lung Cancer
Reposted with permission by the Indiana University School of Medicine. Indiana University School of Medicine researcher Bryan P. Schneider, MD, is leading a novel nationwide […]
Rush University Medical Center is a not-for-profit, 664-bed academic medical center in Chicago. It is nationally and internationally known for many specialties of care, areas […]
A Phase II Study of Cisplatin, 5-Fluorouracil (5-FU), Radiation Therapy and Celecoxib for Resectable Esophageal Cancer – HOG GI 00-16
Facebook
Hoosier Cancer Research Network on Facebook
Linked In
You Tube
Twitter